Biohaven Pharmaceutical Holding Company Ltd.
Equities
BHVN
VGG111961055
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
37.99 USD | -1.89% | +2.45% | -74.97% |
15/05 | Biohaven Insider Bought Shares Worth $512,877, According to a Recent SEC Filing | MT |
14/05 | Biohaven Insider Bought Shares Worth $1,002,470, According to a Recent SEC Filing | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe1st Jan change | Capi. | |
---|---|---|
-74.97% | 54Cr | |
+64.23% | 6.26TCr | |
-2.31% | 4.12TCr | |
+45.21% | 4.03TCr | |
-8.29% | 2.79TCr | |
+11.97% | 2.62TCr | |
-21.16% | 1.91TCr | |
+7.54% | 1.31TCr | |
+27.17% | 1.21TCr | |
+25.72% | 1.23TCr |
- Stock Market
- Equities
- BHVN Stock
- News Biohaven Pharmaceutical Holding Company Ltd.
- Transcript : Biohaven Pharmaceutical Holding Company Ltd., Q3 2020 Earnings Call, Nov 09, 2020